A groundbreaking shift in Canadian drug policy has occurred, as the authorities announce the availability of psilocybin hallucinogens for therapeutic purposes. Until now, these substances were heavily restricted, but a growing body of evidence suggests they could offer aid for psychological conditions like PTSD. This development represents a major